The cGAS-STING pathway and cancer

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway is a key innate immune sensor activated by DNA.
• This pathway plays a significant role in anti-tumor immunity and can influence cancer development and progression.

Purpose of the Study:

• To review the multifaceted roles of cGAS-STING signaling in cancer.
• To discuss how tumor-associated processes and cancer therapies interact with cGAS-STING.
• To highlight current and future therapeutic strategies targeting the cGAS-STING axis in oncology.

Main Methods:

• Literature review and synthesis of existing research on cGAS-STING pathway in cancer.
• Analysis of studies investigating the impact of cGAS-STING on tumorigenesis, metastasis, and therapy response.
• Discussion of emerging concepts and therapeutic approaches.

Main Results:

• cGAS-STING signaling can have both pro-tumor and anti-tumor effects depending on the context.
• Tumor microenvironment and cancer treatments can modulate cGAS-STING activity.
• Targeting the cGAS-STING pathway presents a promising therapeutic avenue.

Conclusions:

• The cGAS-STING pathway is a critical regulator of cancer immunity with complex implications.
• Understanding its dual role is essential for developing effective cancer immunotherapies.
• Further research into cGAS-STING biology will unlock new therapeutic opportunities.